Award-winning actor and producer Sterling K. Brown joins Bristol-Myers Squibb in effort to share stories of What It's Like to Live with Cancer Today

Bristol-Myers SquibbTwo-time Emmy Award winner Sterling K. Brown (This Is Us, Black Panther) is partnering with Bristol-Myers Squibb on a series designed to illuminate the triumphs and challenges of life after a cancer diagnosis. Survivorship Today: What It's Like to Live with Cancer explores the stories of people who have experienced lasting physical, emotional and social effects from cancer to build greater understanding of, and draw attention to, survivorship-related issues.

Today, more people who have been diagnosed with cancer are able to live with the disease than ever before. During this time of rapid progress in cancer treatment, researchers are only just beginning to understand the long-term impacts of the disease on individuals and their loved ones. As the number of cancer survivors in the United States (U.S.) grows to nearly 17 million this year, it is increasingly important to recognize and address the current realities of cancer survivorship. Brown, who lost his uncle to cancer, is speaking with people around the country who have been impacted by the disease to find out what it's like to live with cancer today.

"When my uncle, Sonny, passed away from cancer just six months after his diagnosis, my entire family was devastated. Now, 15 years later, many people with cancer are living longer," said Brown. "While that means they might have a chance to celebrate another birthday or watch their children have children, it also means their lives have likely been forever changed. Survivorship Today will bring these experiences to light to show the long-term effects of cancer, with the goal of helping people feel supported every step of their journey."

Through the stories of people affected by cancer, the series will delve into topics such as:

  • Overcoming barriers: Some people who are diagnosed with cancer face a greater burden of the disease due to their unique circumstances, whether at home, at work or in their communities, which can affect them from diagnosis through treatment and beyond.
  • Impact on emotional and mental health: A person diagnosed with cancer is twice as likely to experience mental health problems compared to a person without the disease. These impacts can be even greater for individuals diagnosed as a young adult and can persist long after treatment ends.
  • Relationships afterward: Cancer touches all those who care about the person living with the disease. It deeply affects friends and family on emotional and physical levels as they do their best to support their loved one over time.

"Living long-term with cancer is a relatively new idea. We've made tremendous progress in addressing the disease itself, but we still need to answer the question of what comes next, outside of treatment," said Adam Lenkowsky, Head of U.S. Oncology, Bristol-Myers Squibb. "By bringing cancer survivorship into greater focus with this series, our goal is to help start a dialogue on the realities of living with cancer, so we can work together toward a day when all people with cancer can live longer, healthier lives and get the support they need."

Watch the series at SurvivorshipToday.com.

About Survivorship Today

Survivorship Today: What It's Like to Live with Cancer is an initiative by Bristol-Myers Squibb that, through the stories of people living with cancer, aims to advance our understanding of what it's like to live with the disease today and inspire action to provide better support.

About Cancer Survivorship

Cancer survivorship refers to the time from diagnosis throughout the remainder of a person’s life. There are nearly 17 million cancer survivors in the U.S. today. Over the next 10 years, this number is projected to increase to nearly 22 million. Today, more than 67 percent of people living with cancer have been alive for at least five years after their initial diagnosis, and more than 45 percent of people have been alive 10 years after diagnosis. However, many people living with cancer feel unprepared for life after active treatment.

About Bristol-Myers Squibb

Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.

Most Popular Now

Pfizer's elranatamab granted FDA Breakthrough Ther…

Pfizer Inc. (NYSE:PFE) announced its investigational cancer immunotherapy, elranatamab, received Breakthrough Therapy Designation from the U.S. Food and Drug Administrati...

Salvat Laboratories announces submission of New Dr…

Salvat Laboratories announced that it has submitted a New Drug Application (NDA) to the FDA for the approval of the first ocular corticosteroid formulated in a nanoemulsi...

New insights on antibody responses to Omicron vari…

Knowing how well vaccination against one SARS-CoV-2 strain (with or without previous infection) counteracts infection with a different strain is a critical research quest...

The origin-of-life molecule, a key to cancer resea…

RNA, the molecule that gave rise to life, has been shown to be essential for repairing human genetic material and preventing mutations that might lead to developing cance...

Bayer with continued strong performance

The Bayer Group maintained its strong business performance across all three divisions in the third quarter. "Despite rising inflation and global supply chain problems, we...

Vividion Therapeutics names Jenna Goldberg as Chie…

Vividion Therapeutics, Inc., a biopharmaceutical company utilizing novel discovery technologies to unlock high value, traditionally undruggable targets with precision the...

Sugar molecules as a target in cancer therapy

Cancer cells use sugar molecules on their surface to disable attacks by the body's immune system. Researchers at the University of Basel now report on how this mechanism ...

COVID vaccination improves effectiveness of cancer…

Patients with nasopharyngeal cancer are often treated with drugs that activate their immune system against the tumor. Until now, it was feared that vaccination against Co...

Pfizer and BioNTech receive positive CHMP opinion …

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced a booster dose of their Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine (COMIRNATY® Original/Omicron ...

Making melanoma immortal: Pitt scientists discover…

Scientists at the University of Pittsburgh School of Medicine have discovered the missing puzzle piece in the mystery of how melanoma tumors control their mortality. I...

Study reveals vaccine confidence declined consider…

A new study suggests that, despite the success of the COVID-19 vaccination campaigns, vaccine confidence has declined significantly since the start of the pandemic. Re...

New drug shows promise for fighting both COVID-19 …

While vaccination can provide life-saving protection against COVID-19, scientists are still searching for ways to treat severe infections, including in people who cannot ...